Cardiac Guidance vs Lung AI
AI Verdict
Choose Cardiac Guidance if…
Choose Cardiac Guidance if your primary objective is to empower healthcare professionals, including those without extensive prior ultrasound experience, to acquire diagnostic-quality cardiac ultrasound images at the point of care. This tool is ideal for settings where real-time AI guidance, automated quality assessment, and precise left ventricular ejection fraction (LVEF) calculation are crucial for accurate cardiac assessments using compatible general-purpose ultrasound systems.
View Cardiac Guidance →Choose Lung AI if…
Choose Lung AI if you require a highly portable, integrated handheld ultrasound device for rapid, on-device AI-powered assessment of both lung pathologies and key cardiac indicators. This tool is particularly well-suited for scenarios demanding immediate insights into conditions like pleural effusion or consolidation, especially in environments where mobility, offline AI processing, and a comprehensive handheld solution are critical.
View Lung AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiac Guidance | Lung AI |
|---|---|---|
| Deployment | Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care. | Cloud-based, integrated with existing platforms (e.g., RapidAI), and potentially on-premise. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiac GuidanceTool A, Cardiac Guidance, offers explicit 'turn-by-turn on-screen probe movement instructions' and an 'Automated quality assessment with a 'Quality Meter'' designed for non-expert ultrasound users. While Tool B also provides guided image capture and real-time feedback, Tool A's detailed, real-time guidance for probe manipulation appears to offer a more direct and immediate path to acquiring diagnostic-quality images for novices.
Clinical Value
Cardiac GuidanceTool A is FDA-cleared to help acquire and interpret diagnostic-quality cardiac ultrasound images, including automated left ventricular ejection fraction (EF) calculation, a key quantitative metric for cardiac function. While Tool B offers AI-powered detection for lung pathologies and cardiac indicators, Tool A's specific focus on comprehensive cardiac assessment with quantitative EF calculation provides a deeper and more directly actionable diagnostic value for cardiology.
Pricing & Value
TieBoth Tool A and Tool B have opaque pricing models, with information only available by contacting the vendor. Without any publicly disclosed pricing details or comparative cost structures, it is impossible to assess or compare their relative value propositions.
Enterprise Readiness
Cardiac GuidanceTool A deploys as a 'Software accessory integrated with compatible general purpose diagnostic ultrasound systems,' allowing it to integrate with existing hospital infrastructure and equipment. In contrast, Tool B's 'On-device' deployment, integrated with the Exo Iris handheld ultrasound device, may require a new hardware investment or a shift in existing equipment protocols for enterprises.
Innovation
Lung AITool B demonstrates higher innovation by pioneering a high-performance, handheld ultrasound platform with on-device AI processing that operates without internet, enhancing portability and accessibility. Additionally, its 'Exo U' AI-powered POCUS education and training platform represents a novel approach to user empowerment and skill development.
Support & Docs
Lung AITool B explicitly features 'Exo U (AI-powered POCUS education and training),' which is a dedicated and innovative resource for user support and continuous learning. Tool A's documentation and support offerings are not specifically highlighted in the provided information or readily available online as a distinct feature.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiac Guidance | Lung AI |
|---|---|---|
| Tool Name | Cardiac Guidance | Lung AI |
| Company | Caption Health | Exo |
| Primary AI Focus (Key Detections/Guidance) | Real-time AI guidance for cardiac ultrasound image acquisition; turn-by-turn on-screen probe movement instructions; automated quality assessment; auto-capture of diagnostic-quality images. | AI-powered detection of pleural effusion; AI-powered detection of consolidation/atelectasis; real-time feedback and image quality monitoring (SweepAI); automated AI-based indicators for cardiac conditions. |
| Automated Quantitative Measurements | Automated left ventricular ejection fraction (EF) calculation (Caption Interpretation). | Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy). |
| Supported Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Emergency Medicine, Pulmonology |
| Designed for Non-Expert Users | Designed for use by non-expert ultrasound users. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Cardiac Guidance and Lung AI.